Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2007 | 04-2007 | 01-2007 | 10-2006 | 07-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 730 | 2,230 | 3,260 | 3,870 | 4,720 |
| Marketable Securities | 700 | 0 | 0 | 0 | 0 |
| Receivables | 8 | 110 | 80 | 50 | 50 |
| Inventories | 240 | 240 | 230 | 210 | 170 |
| Other current assets | 12 | 0 | 40 | 60 | 4 |
| TOTAL | $1,690 | $2,580 | $3,610 | $4,190 | $5,060 |
| Non-Current Assets | |||||
| PPE Net | 969 | N/A | N/A | N/A | 353 |
| Intangibles | 2,176 | 0 | 0 | 0 | 2,137 |
| Other Non-Current Assets | -955 | 2,260 | 2,320 | 2,440 | 40 |
| TOTAL | $2,190 | $2,260 | $2,320 | $2,440 | $2,530 |
| Total Assets | $4,860 | $5,840 | $6,350 | $7,080 | $7,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 420 | 420 | 250 | 120 | 330 |
| Accrued Expenses | 70 | 90 | 80 | 120 | 70 |
| TOTAL | $500 | $520 | $340 | $250 | $410 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $500 | $520 | $340 | $250 | $410 |
| Shareholders' Equity | |||||
| Common Shares | 26,520 | 28,060 | 27,880 | 27,680 | 27,540 |
| Retained earnings | -24,890 | -22,980 | -22,110 | -21,100 | -20,230 |
| Other shareholders' equity | 250 | 230 | 240 | 240 | 240 |
| TOTAL | $4,360 | $5,310 | $6,010 | $6,820 | $7,550 |
| Total Liabilities And Equity | $4,860 | $5,830 | $6,350 | $7,070 | $7,960 |